PXN (Paxillin) is involved in focal adhesion and cytoskeletal reorganization, and is associated with enhanced motility and epithelial – mesenchymal transition (EMT) in cancers (Sohn and Chay 2019; Wen et al. 2020; Tae et al. 2024). The gene discussed is PXN; the disease is cancer.